Fidelity International’s China Biologic Products Holdings, Inc. CBPO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-159,317
| Closed | -$18.9M | – | 1159 |
|
|
2021
Q1 | $18.9M | Sell |
159,317
-150,946
| -49% | -$17.9M | 0.02% | 446 |
|
|
2020
Q4 | $36.6M | Hold |
310,263
| – | – | 0.05% | 342 |
|
|
2020
Q3 | $34.5M | Hold |
310,263
| – | – | 0.04% | 332 |
|
|
2020
Q2 | $31.7M | Sell |
310,263
-62,100
| -17% | -$6.65M | 0.04% | 329 |
|
|
2020
Q1 | $40.2M | Sell |
372,363
-38,354
| -9% | -$4.41M | 0.07% | 256 |
|
|
2019
Q4 | $47.8M | Sell |
410,717
-4,365
| -1% | -$506K | 0.07% | 267 |
|
|
2019
Q3 | $47.5M | Sell |
415,082
-129
| -0% | -$12.8K | 0.07% | 255 |
|
|
2019
Q2 | $39.6M | Sell |
415,211
-103,860
| -20% | -$9.78M | 0.06% | 283 |
|
|
2019
Q1 | $47.4M | Buy |
519,071
+8,929
| +2% | +$731K | 0.07% | 244 |
|
|
2018
Q4 | $38.7M | Sell |
510,142
-29,629
| -5% | -$2.18M | 0.07% | 253 |
|
|
2018
Q3 | $43.2M | Sell |
539,771
-11,845
| -2% | -$1.1M | 0.06% | 278 |
|
|
2018
Q2 | $54.8M | Buy |
551,616
+199,178
| +57% | +$17.2M | 0.08% | 250 |
|
|
2018
Q1 | $28.5M | Sell |
352,438
-278,143
| -44% | -$22.5M | 0.08% | 217 |
|
|
2017
Q4 | $49.7M | Sell |
630,581
-284,267
| -31% | -$23.6M | 0.14% | 166 |
|
|
2017
Q3 | $84.4M | Buy |
914,848
+53,225
| +6% | +$5.11M | 0.24% | 108 |
|
|
2017
Q2 | $97.4M | Sell |
861,623
-17,146
| -2% | -$1.92M | 0.28% | 102 |
|
|
2017
Q1 | $88M | Buy |
878,769
+27,493
| +3% | +$2.94M | 0.25% | 104 |
|
|
2016
Q4 | $91.5M | Buy |
851,276
+146,626
| +21% | +$17.1M | 0.27% | 101 |
|
|
2016
Q3 | $87.7M | Buy |
704,650
+435,581
| +162% | +$51.4M | 0.26% | 100 |
|
|
2016
Q2 | $28.6M | Buy |
269,069
+99,643
| +59% | +$11.6M | 0.09% | 192 |
|
|
2016
Q1 | $19.4M | Sell |
169,426
-252,097
| -60% | -$29.6M | 0.06% | 249 |
|
|
2015
Q4 | $60M | Sell |
421,523
-111,263
| -21% | -$12.8M | 0.18% | 124 |
|
|
2015
Q3 | $47.9M | Buy |
532,786
+80,372
| +18% | +$8.48M | 0.17% | 136 |
|
|
2015
Q2 | $52.1M | Buy |
452,414
+92,450
| +26% | +$9.71M | 0.17% | 144 |
|
|
2015
Q1 | $34.4M | Buy |
359,964
+116,264
| +48% | +$8.7M | 0.11% | 178 |
|
|
2014
Q4 | $16.4M | Buy |
243,700
+16,154
| +7% | +$1M | 0.06% | 290 |
|
|
2014
Q3 | $12.3M | Buy |
227,546
+1,738
| +0.8% | +$85.5K | 0.05% | 310 |
|
|
2014
Q2 | $10M | Buy |
+225,808
| New | +$9.22M | 0.04% | 342 |
|
Fidelity International's CBPO Position: Q2 2021 in Review
Fidelity International sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2021, closing a stake of 159,317 shares — an estimated $18.9M sold.
Fidelity International first reported a position in CBPO in Q2 2014 and held it in 28 quarters. The position peaked at $97.4M in Q2 2017. 0 funds tracked by Wall St. Rank hold CBPO as of Q2 2021.
- Fidelity International reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2021 after selling out during the quarter.
- Fidelity International sold 159,317 China Biologic Products Holdings, Inc. shares in Q2 2021, an estimated $18.9M.
- Fidelity International first reported a position in China Biologic Products Holdings, Inc. in Q2 2014 and held it in 28 quarters.
- Fidelity International's China Biologic Products Holdings, Inc. position peaked at $97.4M in Q2 2017.
- 0 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2021.
Based on Fidelity International's 13F filing for Q2 2021, filed 13 Aug 2021.